View Section: Eyestock Rating
Nugenerex Fair Value
NU
NUGX stock is not valued by Eyestock.
The company does not have a valuation due to the unstable frequency of reports
Discover Undervalued Companies
Nugenerex Valuation
Price chart is not available
1y
3y
5y
All time
Market price
Current market price
Fair value
Min value
Max value
23.12.2024
Market price:
* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.
Nugenerex Immuno-Oncology Inc price metrics
-99.15
Annual return (geometric mean)
1274.21
Risk (standard deviation) of returns
β
255.98
Beta (volatility compared to market)
It means that NUGX stock is more volatile than the broader market
View Section: Profitability